(Q37955877)

25 August 2017

title

Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

25 August 2017

1 reference

0 references

1 reference

1

Melania Manco

1 reference

25 August 2017

publication date

1 October 2011

1 reference

Journal of the American College of Nutrition

25 August 2017

published in

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

295-303

1 reference

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Are children the future of type 2 diabetes prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

The stunned beta cell: a brief history

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Effects of dietary fatty acids on insulin sensitivity and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

21 January 2018

Metabolic flexibility

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2011.10719972

10.1080/07315724.2011.10719972

21 January 2018

Identifiers

DOI

1 reference

release_bkurtwniybdalae6fonixtjpia

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bkurtwniybdalae6fonixtjpia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference